Skip to main content

Table 1 Current use of adjunct medications: antipsychotics, antidepressants, and other mood stabilizers

From: Long-term response to mood stabilizer treatment and its clinical correlates in patients with bipolar disorders: a retrospective observational study

Category

Drug

Good responders (N = 27)

Moderate/poor responders (N = 53)

Antipsychotics, N (%)

Quetiapine under 50 mg

0 (0.0)

4 (7.5)

Quetiapine over 50 mg

5 (18.5)

16 (30.2)

Risperidone

1 (3.7)

8 (15.1)

Olanzapine

4 (14.8)

5 (9.4)

Ziprasidone

0 (0.0)

3 (5.7)

Aripiprazole

0 (0.0)

9 (17.0)

Paliperidone

0 (0.0)

2 (3.8)

Clozapine

1 (3.7)

3 (5.7)

Amisulpride

1 (3.7)

1 (1.9)

Blonanserin

1 (3.7)

1 (1.9)

Antidepressants, N (%)

Any

0 (0.0)

0 (0.0)

Other mood

Lamotrigine

4 (14.8)

4 (7.5)

Stabilizers, N (%)

Carbamazepine

0 (0.0)

1 (1.9)

Mood stabilizer polypharmacy, N (%)a

 

14 (51.9)

43 (81.1)

Total number of mood stabilizers, mean (SD)a

 

1.7 (0.8)

2.2 (0.8)

  1. At the time of the assessment of treatment response
  2. aIncluding index medications, atypical antipsychotics, and other mood stabilizers; for quetiapine, daily dose of 50 mg or less which is usually applied for insomnia control was excluded